| Names | |
|---|---|
| Preferred IUPAC name
1-(2,3-Dichlorophenyl)piperazine | |
| Identifiers | |
3D model (JSmol) |
|
| ChemSpider | |
| ECHA InfoCard | 100.126.497 |
PubChem CID |
|
| UNII | |
CompTox Dashboard (EPA) |
|
| |
| |
| Properties | |
| C10H12Cl2N2 | |
| Molar mass | 231.12 g/mol |
| Appearance | brown oil |
| Density | 1.272g/cm3 °C |
| Melting point | 242 to 244 °C (468 to 471 °F; 515 to 517 K) |
| Boiling point | 365.1 °C (689.2 °F; 638.2 K) at 760mmHg |
| Hazards | |
| Flash point | 174.6 °C (346.3 °F; 447.8 K) |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
| |
2,3-Dichlorophenylpiperazine (2,3-DCPP or DCPP) is a chemical compound from the phenylpiperazine family. It is both a precursor in the synthesis of aripiprazole and one of its metabolites. It is unclear whether 2,3-DCPP is pharmacologically active as a serotonin receptor agonist similar to its close analogue 3-chlorophenylpiperazine (mCPP), though it has been shown to act as a partial agonist of the dopamine D2 and D3 receptors.
2,3-DCPP has been made illegal in Japan and Hungary after having been identified in seized designer drug samples.

The positional isomer 3,4-dichlorophenylpiperazine (3,4-DCPP) is also known, and acts as both a serotonin releaser via the serotonin transporter, and a β1-adrenergic receptor blocker, though with relatively low affinity at both targets.